Comment les comportements de vie sont-ils liés aux facteurs de risque ?
Les études de cohortes évaluent comment les habitudes de vie influencent l'apparition de maladies.
Comportements de viePrévention des maladies
#5
Les études de cohortes peuvent-elles révéler des facteurs de risque modifiables ?
Oui, elles identifient des comportements ou expositions pouvant être modifiés pour réduire les risques.
Facteurs de risque modifiablesInterventions préventives
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Études de cohortes : Questions médicales les plus fréquentes",
"headline": "Études de cohortes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Études de cohortes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-15",
"dateModified": "2026-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Études de cohortes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Études épidémiologiques",
"url": "https://questionsmedicales.fr/mesh/D016021",
"about": {
"@type": "MedicalCondition",
"name": "Études épidémiologiques",
"code": {
"@type": "MedicalCode",
"code": "D016021",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Études de suivi",
"alternateName": "Follow-Up Studies",
"url": "https://questionsmedicales.fr/mesh/D005500",
"about": {
"@type": "MedicalCondition",
"name": "Études de suivi",
"code": {
"@type": "MedicalCode",
"code": "D005500",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.750.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Études longitudinales",
"alternateName": "Longitudinal Studies",
"url": "https://questionsmedicales.fr/mesh/D008137",
"about": {
"@type": "MedicalCondition",
"name": "Études longitudinales",
"code": {
"@type": "MedicalCode",
"code": "D008137",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.750.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Étude longitudinale sur la santé des adolescents aux États-Unis",
"alternateName": "National Longitudinal Study of Adolescent Health",
"url": "https://questionsmedicales.fr/mesh/D063588",
"about": {
"@type": "MedicalCondition",
"name": "Étude longitudinale sur la santé des adolescents aux États-Unis",
"code": {
"@type": "MedicalCode",
"code": "D063588",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.750.500.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Études prospectives",
"alternateName": "Prospective Studies",
"url": "https://questionsmedicales.fr/mesh/D011446",
"about": {
"@type": "MedicalCondition",
"name": "Études prospectives",
"code": {
"@type": "MedicalCode",
"code": "D011446",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.750.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Études rétrospectives",
"alternateName": "Retrospective Studies",
"url": "https://questionsmedicales.fr/mesh/D012189",
"about": {
"@type": "MedicalCondition",
"name": "Études rétrospectives",
"code": {
"@type": "MedicalCode",
"code": "D012189",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.750.825"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Études de cohortes",
"alternateName": "Cohort Studies",
"code": {
"@type": "MedicalCode",
"code": "D015331",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Hossein Poustchi",
"url": "https://questionsmedicales.fr/author/Hossein%20Poustchi",
"affiliation": {
"@type": "Organization",
"name": "Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Reza Malekzadeh",
"url": "https://questionsmedicales.fr/author/Reza%20Malekzadeh",
"affiliation": {
"@type": "Organization",
"name": "Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. malek@tums.ac.ir."
}
},
{
"@type": "Person",
"name": "Zhanmo Ni",
"url": "https://questionsmedicales.fr/author/Zhanmo%20Ni",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Priya Duggal",
"url": "https://questionsmedicales.fr/author/Priya%20Duggal",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Causes and predictors of premature death in the pars cohort study, Iran: a cohort study.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39334044",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-024-19583-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cohort profile: the CARTaGENE Cohort Nutrition Study (Quebec, Canada).",
"datePublished": "2024-08-17",
"url": "https://questionsmedicales.fr/article/39153764",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2023-083425"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cohort profile: China undergraduate cohort for environmental health study.",
"datePublished": "2024-03-15",
"url": "https://questionsmedicales.fr/article/38491371",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-024-17915-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health literacy - study protocol for LiSa cohort study.",
"datePublished": "2024-06-29",
"url": "https://questionsmedicales.fr/article/38951815",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-024-19148-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cohort profile: a nationwide study in Dutch",
"datePublished": "2024-10-09",
"url": "https://questionsmedicales.fr/article/39384226",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2024-086688"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Caractéristiques des études épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D016020"
},
{
"@type": "ListItem",
"position": 6,
"name": "Études épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D016021"
},
{
"@type": "ListItem",
"position": 7,
"name": "Études de cohortes",
"item": "https://questionsmedicales.fr/mesh/D015331"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Études de cohortes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Études de cohortes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Études de cohortes",
"description": "Comment les études de cohortes aident-elles au diagnostic ?\nPeut-on utiliser des études de cohortes pour diagnostiquer des maladies rares ?\nQuel est le rôle des biomarqueurs dans les études de cohortes ?\nLes études de cohortes peuvent-elles confirmer un diagnostic ?\nComment les critères de diagnostic sont-ils établis dans ces études ?",
"url": "https://questionsmedicales.fr/mesh/D015331#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Études de cohortes",
"description": "Les études de cohortes identifient-elles des symptômes spécifiques ?\nComment les symptômes sont-ils mesurés dans ces études ?\nLes études de cohortes peuvent-elles révéler des symptômes précoces ?\nPeut-on observer des variations de symptômes dans les cohortes ?\nLes cohortes aident-elles à comprendre la progression des symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D015331#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Études de cohortes",
"description": "Comment les études de cohortes contribuent-elles à la prévention ?\nPeut-on évaluer l'impact des programmes de prévention avec des cohortes ?\nLes cohortes aident-elles à identifier des populations à risque ?\nComment les comportements de santé sont-ils étudiés dans ces cohortes ?\nLes études de cohortes peuvent-elles influencer les politiques de santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D015331#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Études de cohortes",
"description": "Les études de cohortes évaluent-elles l'efficacité des traitements ?\nComment les traitements sont-ils analysés dans ces études ?\nLes études de cohortes peuvent-elles influencer les recommandations de traitement ?\nPeut-on étudier des traitements alternatifs avec des cohortes ?\nLes cohortes aident-elles à identifier des effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D015331#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Études de cohortes",
"description": "Les études de cohortes identifient-elles des complications des maladies ?\nComment les complications sont-elles mesurées dans ces études ?\nPeut-on étudier la relation entre traitement et complications ?\nLes cohortes aident-elles à prédire les complications futures ?\nLes études de cohortes peuvent-elles révéler des complications inattendues ?",
"url": "https://questionsmedicales.fr/mesh/D015331#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Études de cohortes",
"description": "Comment les études de cohortes identifient-elles des facteurs de risque ?\nPeut-on étudier des facteurs de risque environnementaux avec des cohortes ?\nLes cohortes aident-elles à comprendre les facteurs génétiques ?\nComment les comportements de vie sont-ils liés aux facteurs de risque ?\nLes études de cohortes peuvent-elles révéler des facteurs de risque modifiables ?",
"url": "https://questionsmedicales.fr/mesh/D015331#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment les études de cohortes aident-elles au diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles identifient des associations entre facteurs de risque et maladies, facilitant le diagnostic précoce."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des études de cohortes pour diagnostiquer des maladies rares ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent aider à identifier des cas en suivant des groupes spécifiques exposés à des risques."
}
},
{
"@type": "Question",
"name": "Quel est le rôle des biomarqueurs dans les études de cohortes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les biomarqueurs aident à évaluer l'exposition et à prédire les résultats de santé dans les cohortes."
}
},
{
"@type": "Question",
"name": "Les études de cohortes peuvent-elles confirmer un diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent fournir des preuves supplémentaires, mais ne remplacent pas un diagnostic clinique."
}
},
{
"@type": "Question",
"name": "Comment les critères de diagnostic sont-ils établis dans ces études ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent basés sur des définitions standardisées et des résultats d'études antérieures."
}
},
{
"@type": "Question",
"name": "Les études de cohortes identifient-elles des symptômes spécifiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent relier des symptômes à des facteurs de risque dans des populations suivies."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils mesurés dans ces études ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent évalués par des questionnaires standardisés ou des examens cliniques."
}
},
{
"@type": "Question",
"name": "Les études de cohortes peuvent-elles révéler des symptômes précoces ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent détecter des symptômes précoces en suivant des groupes à risque sur le long terme."
}
},
{
"@type": "Question",
"name": "Peut-on observer des variations de symptômes dans les cohortes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les variations peuvent être liées à des facteurs environnementaux ou génétiques observés."
}
},
{
"@type": "Question",
"name": "Les cohortes aident-elles à comprendre la progression des symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent d'analyser comment les symptômes évoluent avec le temps et les traitements."
}
},
{
"@type": "Question",
"name": "Comment les études de cohortes contribuent-elles à la prévention ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles identifient des facteurs de risque, permettant de développer des stratégies de prévention ciblées."
}
},
{
"@type": "Question",
"name": "Peut-on évaluer l'impact des programmes de prévention avec des cohortes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent d'analyser l'efficacité des programmes de prévention sur des groupes suivis."
}
},
{
"@type": "Question",
"name": "Les cohortes aident-elles à identifier des populations à risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent de repérer des groupes vulnérables nécessitant des interventions préventives."
}
},
{
"@type": "Question",
"name": "Comment les comportements de santé sont-ils étudiés dans ces cohortes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent évalués par des questionnaires sur les habitudes de vie et les comportements de santé."
}
},
{
"@type": "Question",
"name": "Les études de cohortes peuvent-elles influencer les politiques de santé publique ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les résultats peuvent orienter les politiques de santé en matière de prévention et d'éducation."
}
},
{
"@type": "Question",
"name": "Les études de cohortes évaluent-elles l'efficacité des traitements ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles comparent les résultats de santé entre différents traitements dans des groupes suivis."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils analysés dans ces études ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont analysés en fonction des résultats de santé et des effets secondaires observés dans les cohortes."
}
},
{
"@type": "Question",
"name": "Les études de cohortes peuvent-elles influencer les recommandations de traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les résultats peuvent guider les pratiques cliniques et les recommandations de traitement."
}
},
{
"@type": "Question",
"name": "Peut-on étudier des traitements alternatifs avec des cohortes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent évaluer l'impact de traitements alternatifs sur des groupes spécifiques."
}
},
{
"@type": "Question",
"name": "Les cohortes aident-elles à identifier des effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent de suivre les effets secondaires sur le long terme dans des populations exposées."
}
},
{
"@type": "Question",
"name": "Les études de cohortes identifient-elles des complications des maladies ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent de suivre l'apparition de complications dans des groupes à risque."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles mesurées dans ces études ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont souvent évaluées par des examens cliniques et des rapports de patients sur leur état."
}
},
{
"@type": "Question",
"name": "Peut-on étudier la relation entre traitement et complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les cohortes permettent d'analyser comment différents traitements influencent les complications."
}
},
{
"@type": "Question",
"name": "Les cohortes aident-elles à prédire les complications futures ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent identifier des facteurs prédictifs de complications dans des populations suivies."
}
},
{
"@type": "Question",
"name": "Les études de cohortes peuvent-elles révéler des complications inattendues ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent mettre en lumière des complications non anticipées liées à des traitements ou des expositions."
}
},
{
"@type": "Question",
"name": "Comment les études de cohortes identifient-elles des facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles comparent l'exposition à des facteurs dans des groupes avec et sans maladie sur le long terme."
}
},
{
"@type": "Question",
"name": "Peut-on étudier des facteurs de risque environnementaux avec des cohortes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent d'analyser l'impact des facteurs environnementaux sur la santé des populations."
}
},
{
"@type": "Question",
"name": "Les cohortes aident-elles à comprendre les facteurs génétiques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent explorer les interactions entre facteurs génétiques et environnementaux sur la santé."
}
},
{
"@type": "Question",
"name": "Comment les comportements de vie sont-ils liés aux facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les études de cohortes évaluent comment les habitudes de vie influencent l'apparition de maladies."
}
},
{
"@type": "Question",
"name": "Les études de cohortes peuvent-elles révéler des facteurs de risque modifiables ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles identifient des comportements ou expositions pouvant être modifiés pour réduire les risques."
}
}
]
}
]
}
While death in old age is inevitable, premature death at younger ages is within our control. Premature mortality (death < 70 years) is a crucial indicator of health status and access to healthcare, wi...
The Pars Cohort Study is a prospective cohort study conducted in Fars Province, Iran, involving 9,264 individuals aged 40-75 years, 53.8% of whom were women. We assessed participants from baseline (20...
Out of 388 deaths, 54% were premature. The most common causes of premature death included IHD (40%), stroke (11%), road traffic injuries (6%), lower respiratory infections (5%), and COVID-19 (3%). The...
The predominant causes of premature mortality were IHD and stroke. To mitigate premature deaths, it is recommended to address both socioeconomic and behavioral factors simultaneously....
To address emerging nutritional epidemiological research questions, data from contemporary cohorts are needed. CARTaGENE is the largest ongoing prospective cohort study of men and women in Québec, Can...
CARTaGENE recruited over 43 000 men and women aged 40-69 in two phases (A and B). In phase A, a total of 19 784 men and women were enrolled between 2009 and 2010. In 2011-2012, phase A participants of...
Available dietary data include intake of total energy, macronutrients and micronutrients, food group equivalents and a measure of diet quality based on the Canadian Healthy Eating Index 2005 (C-HEI 20...
The CARTaGENE Cohort Nutrition Study is an additional resource of the CARTaGENE platform and is available internationally to examine research questions related to diet and health among contemporary po...
The China Undergraduate Cohort (CUC) is an ambispective cohort study with its major purpose to better understand the effects of lifetime environmental exposures on health outcomes. We recruited 5322 c...
Health literacy is the degree to which individuals have the ability to find, understand, and use information and services to inform health-related decisions and actions for themselves and others, whet...
This is a prospective cohort study that collects data on HL, anxiety and depression, health characteristics, health behavior and sociodemographic data. The study population will be composed by adults ...
The LiSa project is a population-based study, derived from a random sampling technique that will allow the analysis of health outcomes in a representative sample of the population of the municipality ...
Clinical trials: NCT05558631 (registered on 26/09/2022)....
We invited all heterozygous and homozygous...
Mean age at study inclusion was 53 years. Linkage with the Netherlands Cancer Registry showed a younger age at diagnosis in homozygotes (mean age 41.7 years) and heterozygotes (47.9 years) than non-ca...
Further data linkages with the Netherlands Cancer Registry will allow prospective follow-up and breast cancer risk assessment in unaffected women at the time of genetic testing, risk of contralateral ...
According to World Health Organization (WHO), currently, 2.2 billion people are living with visual impairment worldwide, of which almost half could have been prevented. There are both modifiable and u...
Hailey-Hailey disease is a rare hereditary skin disease caused by mutations in the ATP2C1 gene encoding the secretory pathway Ca2+/Mn2+-ATPase 1 (SPCA1) protein. Extracutaneous manifestations of Haile...
The Obesity and Disease Development Sweden (ODDS) study was designed to create a large cohort to study body mass index (BMI), waist circumference (WC) and changes in weight and WC, in relation to morb...
ODDS includes 4 295 859 individuals, 2 165 048 men and 2 130 811 women, in Swedish cohorts and national registers with information on weight assessed once (2 555 098 individuals) or more (1 740 761 in...
Among all weight assessments (of which 85% are objectively measured), the median year, age and BMI (IQR) is 1985 (1977-1994) in men and 2001 (1991-2010) in women, age 19 (18-40) years in men and 30 (2...
The large sample size and long follow-up of the ODDS Study will provide robust results on anthropometric measures in relation to risk of common diseases and causes of deaths, and novel findings in sub...
Three-dimensional (3D) total body photography may improve early detection of melanoma and facilitate surveillance, leading to better prognosis and lower healthcare costs. The Australian Centre of Exce...
A prospective cohort study will enrol 15 000 participants aged 18 years and above, across 15 Australian sites. Participants will attend study visits according to their melanoma risk category: very hig...
The ACEMID cohort study was approved by the Metro South Health Human Research Ethics Committee (approval number: HREC/2019/QMS/57206) and the University of Queensland Human Research Ethics Committee (...
ACTRN12619001706167....
Numerous studies suggest that sex steroids might play a role in sex disparity observed in allergic diseases in adults. However, whether sex hormones influence allergic diseases in children remains unc...
The present cross-sectional study included 145 6-year-old children participating in a pilot birth cohort study in the Japan Environment and Children's Study. Data on allergic diseases were obtained fr...
After adjusted sex, amount of body fat at 6 years, parental history of allergic disease, and exposure to tobacco smoke, serum dehydroepiandrosterone sulfate level was significantly associated with red...
The current study findings suggest that sex hormones may play an important role in the development of allergic diseases in prepubertal children....